Cyclin-dependent kinase inhibitors in restriction point control, genomic stability, and tumorigenesis.
Millard
S S
SS
Program in Molecular Biology and Cell Biology and Genetics, Cornell University Graduate School of Medical Sciences, New York, NY 10021, USA. ssmillar@mail.med.cornell.edu
Koff
A
A
D000818:Animals; D002455:Cell Division / Q000502:physiology; D002471:Cell Transformation, Neoplastic / Q000473:pathology; D018844:Cyclin-Dependent Kinases / Q000037:antagonists & inhibitors*; D016213:Cyclins / Q000502:physiology*; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D006801:Humans; D008869:Microtubule-Associated Proteins / Q000502:physiology
D016213:Cyclins; D004791:Enzyme Inhibitors; D008869:Microtubule-Associated Proteins; D018844:Cyclin-Dependent Kinases